Last update 08 May 2025
VIT University

VIT University

Education|1984|India|
100-250
|
www.vit.ac.in

Overview

Tags

Immune System Diseases
Neoplasms
Skin and Musculoskeletal Diseases
Small molecule drug
Enzyme

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Enzyme1
Top 5 TargetCount
AR x HDACs x KLK31
Peptidoglycan1

Related

2
Drugs associated with VIT University
Diindolylmethane
Target
AR x HDACs x KLK3
Mechanism
AR antagonists [+2]
Active Org.
National Cancer InstituteNational Cancer Institute [+2]
Originator Org.
National Cancer InstituteNational Cancer Institute
Active Indication
Uterine Cervical Cancer [+2]
Inactive Indication
Adenocarcinoma of prostate [+4]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Gp105
Target
Peptidoglycan
Mechanism
Peptidoglycan inhibitors
Active Org.
VIT UniversityVIT University
Originator Org.
VIT UniversityVIT University
Active Indication
Gram-Negative Bacterial Infections
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with VIT University
Login to view more data
0 Patents (Medical) associated with VIT University
Login to view more data
37,598
Literatures (Medical) associated with VIT University
31 Dec 2025Philosophical Magazine Letters
Predictive modeling of ultimate tensile strength in dissimilar friction stir welded aluminum alloys via machine learning approach
31 Dec 2025Energy Sources, Part A: Recovery, Utilization, and Environmental Effects
A Comprehensive Assessment of Large-scale Battery Integrated Hybrid Renewable Energy System to Improve Sustainability of a Smart City
31 Dec 2025Cogent Economics & Finance
Firm-specific determinants influencing tax avoidance among Indian multinational corporations: a panel regression approach
100 Deals associated with VIT University
Login to view more data
100 Translational Medicine associated with VIT University
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Diindolylmethane
 ( AR x HDACs x KLK3 )		Psoriasis
More
Preclinical
Gp105
 ( Peptidoglycan )		Gram-Negative Bacterial Infections
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free